Cell Line |
PR(t) |
PR(p) |
mPR-α (t) |
mPR-β (t) |
PGRMC1 (t) |
ERα (t) |
ERα (p) |
ER β (t) |
ERβ (p) |
GPR30 (t) |
GRP30 (p) |
AR (t) |
AR (p) |
Other |
A172 |
|
|
|
|
|
- |
|
|
|
|
|
|
+ |
|
C6 |
- |
- |
+ |
+ |
+ |
-/+ |
-/+ |
-/+ |
-/+ |
|
|
- |
+ |
|
CAD |
+ |
|
+ |
- |
+ |
|
+ |
|
|
|
|
|
|
|
Cath.a |
|
|
|
|
|
|
- |
|
+ |
|
|
|
|
responsive to steroid hormones |
CNh |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GN11 |
+ |
|
+ |
+ |
|
+ |
+ |
+ |
|
+ |
|
|
|
|
GNV |
|
|
|
|
|
+ |
|
+ |
|
|
|
|
|
|
GT1-7 |
+ |
+ |
+ |
|
|
-/+ |
+ |
+ |
+ |
+ |
|
|
+ |
|
HCN |
|
|
|
|
|
|
|
|
|
|
|
|
|
responsive to estrogen |
HN33 |
|
|
|
|
|
+ |
+ |
+ |
|
+ |
|
|
|
|
HT22 |
- |
|
- |
- |
+ |
-/+ |
-/+ |
-/+ |
-/+ |
+ |
|
-/+ |
|
mERα, Erβ splice variant |
IMR-32 |
|
|
|
|
|
- |
|
|
|
|
|
|
|
|
mHypoE-46 |
|
|
|
|
|
|
+ |
|
+ |
|
|
|
+ |
|
N27 |
- |
|
|
|
|
+ |
+ |
+ |
|
|
|
- |
+ |
|
N2A |
+ |
|
|
|
|
+ |
+ |
+ |
+ |
+ |
|
+ |
|
Erβ splice variant |
NG108-15 |
|
|
|
|
|
+ |
|
|
+ |
|
|
- |
|
|
NLT |
|
|
|
|
|
+ |
|
+ |
|
+ |
|
|
|
|
PC-12 |
+ |
|
+ |
+ |
+ |
- |
|
+ |
+ |
+ |
+ |
-/+ |
+ |
|
SH-SY5Y |
- |
|
- |
- |
|
- |
+ |
- |
+ |
|
|
- |
- |
Delta 7ERα |
SN56 |
+ |
|
+ |
- |
+ |
+ |
+ |
-/+ |
|
+ |
|
+ |
|
m ERα |
T98G |
+ |
|
+ |
+ |
|
-/+ |
|
- |
|
|
|
+ |
+ |
|
U373MG |
|
|
|
|
|
+ |
|
- |
|
|
|
|
|
|
Bold font indicates data only reported from our laboratory, while underlined font indicates data from our laboratory that is consistent with previous reports, t = mRNA transcript, p = protein expression, |
